Onxeo onxeo.com

Onxeo (Paris: ONXEO) is a developer of orphan oncology drugs. The company is focused on developing therapeutics for rare cancers, one of the fastest growing markets in the healthcare industry with high, unmet medical needs. Onxeo's comprehensive portfolio features a broad orphan oncology pipeline, with three independent programs in advanced clinical development, including Onxeo's first approved orphan oncology drug, Beleodaq.

Onxeo (Paris: ONXEO) is a developer of orphan oncology drugs. The company is focused on developing therapeutics for rare cancers, one of the fastest growing markets in the healthcare industry with high, unmet medical needs. Onxeo's comprehensive port...Show all

See All Exits Recent Exits